The early stages of hematopoiesis have been difficult to study due to problems in obtaining homogeneous populations ofprogenitor cells that retain both self-renewal and differentiative capacities. We have developed an in vitro system in which transformation of murine bone-marrow cells with the BCR/ABL oncogene, a gene associated with stem-cell leukemias, leads to the outgrowth of clonal lines that have an early lymphoid progenitor cell phenotype. The progenitor cells retain immunoglobulin heavy and light chain genes in a germ-line configuration. These cells give rise in vitro to pre-B cells that have diverse diversity-joining (D-J) region rearrangements, and on transfer to mice with severe combined immune deficiency, differentiate to surface IgM', immunoglobulinsecreting B cells that respond to T-cell help and function in an antigen-specific fashion. Although their growth is stimulated by BCR/ABL, the progenitor cells depend for continued growth on a stromal cell-derived soluble factor distinct from the pre-B-cell growth factor, interleukin 7.' These fnding show that BCR/ABL can promote proliferation of an early hematopoietic progenitor cell without preventing its differentiation. This system provides a means of studying the complete B-cell developmental process from clonal progenitor cell to end-stage plasma cell.
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B lymphopoiesis occurs in the bone marrow of adult mammals, originating from a pluripotent hematopoietic stem cell (1, 2) . The first descendent of the stem cell identified as committed to the B lineage is the pro-B cell. This cell type is characterized by its lack of rearrangement at the immunoglobulin heavy and light chain loci and lack of expression of the lineage-specific surface antigens B220, MAC-1, and Thy- 1 (3, 4) . The pro-B cell has been thought to differentiate into mature, functional B cells by a series of sequential steps (5, 6) . These stages are defined by rearrangement ofdiversity (D) and joining (J) region segments on at least one allele of the immunoglobulin heavy-chain locus (immature pre-B stage), productive variable (V)-DJ region joining and cytoplasmic IgM expression (pre-B cell), and finally production of functional immunoglobulin light chain and surface expression of IgM, IgD, and Ia molecules (mature B cell).
Due to difficulties in maintaining in culture early hematopoietic progenitors that retain both their self-renewal -and differentiative capacities, very little is known about the signaling mechanisms that commit those cells to the B lineage and/or allow B-cell progenitors to progress from one stage to the next. One approach to this problem has been to manipulate long-term bone-marrow culture conditions to selectively expand B-cell progenitors (7) . Another approach has been to immortalize the progenitor cells by virus transformation (8) (9) (10) . Most of this work has used Abelson murine leukemia virus as the transforming agent. A target of v-abl appears to be a B220', Thy-1 B progenitor (10) , but most lines obtained after transformation are of the pre-B-cell phenotype (11) . Although these lines retain some differentiative potential based on their ability to undergo light chain rearrangement after transformation, efficient differentiation to mature, functional B cells has not been shown.
Several lines of evidence suggest that transformation by the P210 chimeric protein product of the BCR/ABL oncogene may provide a means to stimulate early progenitor cell growth without arresting differentiation. This gene product is found in >90% ofpatients with chronic myeloid leukemia and results from a translocation that juxtaposes portions of the BCR gene on chromosome 22 near the second exon of c-ABL on chromosome 9 (12) . The BCR/ABL translocation appears to occur in a pluripotent stem cell. In the chronic phase of the disease, predominantly myeloid proliferation occurs, although the lymphoid lineage is also affected (12) . Importantly, differentiation is not completely blocked. In vitro, P210-expressing hematopoietic cells and fibroblasts have altered growth characteristics but are not fully transformed (11) .
By modifying conditions established by Whitlock and Witte (13) for long-term bone-marrow culture and by using the BCR/ABL oncogene as a transforming agent, we have derived clonal lymphoid progenitor lines that retain their differentiative capacity. These cells are more immature than populations maintained in other modified long-term bonemarrow cultures, and addition of exogenous cytokines is not required' to maintain an immature phenotype. This system should be useful for studying the molecular mechanisms that regulate B-cell lymphopoiesis.
MATERIALS AND METHODS
Mice and Culture Conditions. BALB/c mice and CB.17 mice homozygous for the mutation for severe combined immune deficiency (SCID mice) (14) were bred and maintained in our colony at the University of California-Los Angeles. Single-cell suspensions of bone-marrow cells isolated from the femurs and tibias of 3-to 4-week-old BALB/c mice were obtained and infected with BCR/ABL-expressing virus (15) . The cells were then washed and plated at 1 X 106 cells per ml in RPMI 1640 medium supplemented with 5% fetal calf serum' and 50 uM 2-mercaptoethanol onto preestablished confluent layers of the stromal cell line S17 (16) pMV6tkneo and the production of viral stocks have been described (15) .
Protein and DNA Analyses. Preparation of lysates, immunoprecipitation, autophosphorylation with [y-32P]ATP, and PAGE of P210 protein from cultured cells was as described (17) with rabbit anti-abl sera pEX-2,3 (17, 18) . High-molecular-weight DNA was prepared and analyzed as described (19 (21) .
RESULTS

Establishment of Clonal Cell Lines with a Progenitor Cell
Phenotype. Lymphoid bone-marrow cultures (LBMC) established under conditions derived by Whitlock and Witte (13) consist of two phases: (i) an adherent layer that provides the lymphokines and cell-cell interactions required for lymphopoiesis and B-cell growth, and (ii) a nonadherent population composed of predominantly pre-B cells but also progenitor cells capable of repopulating the B-lymphocyte compartment of immunodeficient mice (21, 22) . To isolate clonal populations of the progenitor cells, LBMC conditions were modified in two ways (Fig. 1) . (i) The cells were plated onto the clonal stromal line S17 because it has been shown to form a contact-inhibited, confluent adherent layer capable of supporting early B-cell precursors (16) . In these cultures, a bone marrow-derived, heterogeneous adherent layer does not form.
(ii) The bone-marrow cells were infected with a retroviral construct containing the P210 BCR/ABL gene before plating on S17 stroma.
Most cells in cultures established on S17 stroma [referred to as lymphoid progenitor culture (LPC)] had not undergone rearrangement at the immunoglobulin heavy chain locus ( Fig.  2A) . This contrasts markedly with P210-expressing bonemarrow cultures established on a heterogeneous adherent layer that have rearranged immunoglobulin heavy chain but not light chain alleles, characteristic of early pre-B cells (15) . K and T-cell receptor 83 chain genes were also in germ-line configuration in the S17-derived LPC (data not shown).
Phenotypically, the LPC cell appeared similar to a B progenitor recently found to compose 1-2% of normal bone marrow (10) . Approximately 80% of the cells in the cultures expressed the B-lineage markers B220 (53-98%) and BP-1 (60-83%) (data not shown). The cells were negative for the myeloid suiface antigen MAC-1 but expressed low levels of measured by spleen colony (24) or in vitro colony forming assays (25) , respectively (data not shown).
All cultures contained one predominant site of viral integration, indicating that the cultures contained the retroviral genome and that the cells were clonally derived (Fig. 2B) . The cell lines could also be shown to have an integrated copy of the BCR/ABL gene and to express high levels ofABL mRNA of retroviral genome length [-9.5 kilobases (kb)] (data not shown). All P210-infected cultures expressed P210 protein tyrosine kinase activity as measured by immunoprecipitation-autophosphorylation (Fig. 2C) . The kinase activity was shown to result from P210 protein expression in >98% of the cells in most cultures as determined by immunoperoxidase staining (data not shown).
Lymphoid Progenitor Cells Do Not Respond to Interleukin 7 (IL-7). Cultures established on S17 stroma in the absence of BCR/ABL were also of an early lymphoid progenitor cell phenotype and could be maintained long-term in vitro (data not shown). P210-expressing LPCs, however, displayed a 5-to 10-fold increase in cell density compared with uninfected cells. The BCR/ABL-immortalized lines, similar to uninfected cultures, remained dependent on the S17 stroma for growth for >3 months (Table 1 ) and, therefore, were distinguishable from hematopoietic cells transformed with v-abl (13, 26) , src (27) , or myc/ras (19) , which usually become growth-factor independent after several weeks.
LPC could be maintained in 50%o S17 supernatant, suggesting that the role of the S17 stroma was at least partially mediated by soluble factors (Table 1) . IL-7 has been shown to be important for pre-B-cell growth (30) (31) (32) . Production by the S17 stromal line of IL-7 or its mRNA was undetectable by bioassay and polymerase chain reaction (data not shown). In addition, the LPCs could not be maintained in IL-7-containing cell-free supernatants (Table 1) . This contrasts to a pre-B-cell clone, clone 4 (28), which increased 10-fold in cell number over a 5-day period under the same conditions. P210-Expressing LPCs Undergo Immunoglobulin Rearrangements in Vitro. We observed that the cells in the culture (lanes 1-3) or from the human chronic myeloid leukemiaderived line K-562 were immunoprecipitated for tyrosine autophosphorylation assay (17) with site-directed antisera to the second exon of ABL (18) . Samples were analyzed by NaDodSO4/7% PAGE. spontaneously underwent rearrangement at the immunoglobulin heavy chain locus over time, giving rise to immature pre-B cells with diverse D-J rearrangements (Fig. 3) (21, 22) . SCID mice are devoid of cellular and humoral immune function and are congenic with LPC cells of BALB/c origin (14) . Thirty to 60 days after transfer of 1 x 106 LPC cells, the number of splenocytes in the LPC-reconstituted SCID mice was, on average, 5 times higher than in unreconstituted SCID mice and was comparable to normal BALB/c mice or SCID mice reconstituted with LBMC (Table 2 ). Thirty to 50% of the splenocytes in LPC-reconstituted mice were B220+. We confirmed that 0.2 9.6 0.1% 0.9 ND P210-expressing LPC cells used in the assay were harvested from cultures 4-6 weeks after initiation. The pre-B-cell line was the cytoplasmic IgM' line, clone 4, which was derived from LBMC (28) . Cells were washed and plated at 1 x 105 cells per ml; cell number was determined on day 5. The source of IL-7 was an IL-7-containing COS cell supernatant (29) . S17 supernatant was collected from a confluent S17 stromal layer 24 hr after change of medium. ND, not determined. (Table 2) .
Immunoglobulin, predominantly of the IgM isotype, was detected by ELISA in the serum of LPC-reconstituted SCID mice 30 days after transfer (Fig. 4) . The level of serum immunoglobulin was 20-50 times greater than the background levels in unreconstituted SCII) mice. Although 10-fold less than in control BALB/c mice, the level appears to correlate with the 5-to 10-fold lower number of surface IgM+ cells present in the spleens of the reconstituted animals relative to normal mice (Table 2) . To exclude the possibility that the serum immunoglobulin was produced by cells that did not contain the BCR/ ABL/tk-neo construct, additional experiments were conducted in which the LPCs were passaged in medium containing G418 for 2 weeks before transfer in vivo. No decrease in serum immunoglobulin was detected when G418-selected cells were compared with nonselected cells (Fig. 4) . Fig. 2 . GL, germ line. (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) 600 (100-1250) <50 Mice were analyzed 8-10 weeks after reconstitution. Data represent the average of 2-4 mice in control groups and 8-10 mice in experimental groups. Ranges are given in parentheses.
*Anti-TNP titers are expressed as the reciprocal of the serum dilution to give 50o maximum response in an ELISA.
The lack of serum IgG in the LPC-reconstituted mice suggested that either a functional T-cell compartment was not reconstituted in these mice or that the progenitor cells gave rise to cells unable to undergo isotype switch. To test this, nylon wool-passed thymocytes were included in the inoculum as a source of T cells. Serum IgM levels in SCID mice receiving LPC and thymocytes were comparable with SCID mice receiving LPC alone (Fig. 4) . However, mice receiving LPC and thymocytes displayed a substantial increase in serum IgG levels. All subclasses of IgG were detected (data not shown). SCID mice receiving thymocytes alone did not have detectable serum immunoglobulin (data not shown).
P210-Expressing LPCs Give Rise to Antigen-Responsive B Cells. LPC-reconstituted SCID mice were primed and boosted with the antigen TNP-Ficoll 30 days after transfer. TNP-Ficoll was chosen because it does not require T-cell help to elicit an antibody response (34) . Specific anti-TNP antibodies were present in the serum as measured by ELISA (Table 2) (35, 36) . The LPCs described here are not Lyl+ and they are not interleukin 3-dependent (P.A.S. and O.N.W., unpublished work). We cannot exclude the possibility that BCR/ABL abrogates an interleukin 3 requirement. BCR/ABL, however, does not abrogate all cytokine requirements because the cells remain dependent on the S17 stromal layer for growth. IL-7 also does not appear to be the primary factor required for progenitor cell growth. The LPCs cannot be maintained in IL-7-supplemented medium, and the S17 stroma produce minimal, if any, levels of IL-7. Others have indicated that IL-7-dependent lymphoid cells can induce IL-7 production in stromal cells that do not constitutively secrete that cytokine (32) . The observation that the IL-7-dependent clone 4 pre-B cell line does not grow well on S17 stroma would argue against that process as being a generalized phenomenon and lends further support to the hypothesis that the S17 stroma supports B lymphopoiesis without producing IL-7. The absence of IL-7 may be critical in allowing the outgrowth of an earlier cell type than the pre-B cell, which predominates in long-term bone-marrow cultures established on mixed stroma.
The ability of BCR/ABL to stimulate growth without arresting differentiation has precedent in other oncogene systems (37) (38) (39) . A well-characterized system is avian erythroleukemia virus, in which transformation of avian erythroblasts by the oncogene erbB results in growth and differentiation, whereas transformation by erbB plus erbA results in growth only (39) . These findings suggest that complete transformation and differentiation arrest require oncogene cooperativity. The progression of chronic myeloid leukemia lends additional support to this concept. In the chronic phase, there is proliferation and differentiation of predominantly myeloid 
